23andMe Holding Co. (ME)
USD 0.61
(0.0%)
USD 0.61
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -321.35 Million USD | 0.82% |
| 2022 | -324.01 Million USD | -27.49% |
| 2021 | -254.15 Million USD | -37.23% |
| 2020 | -185.19 Million USD | 13.36% |
| 2019 | -213.75 Million USD | -13.23% |
| 2018 | -188.78 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -71.95 Million USD | -22.12% |
| 2023 Q4 | -58.92 Million USD | 79.05% |
| 2023 Q2 | -79.13 Million USD | 27.58% |
| 2023 FY | -321.35 Million USD | 0.82% |
| 2023 Q3 | -281.21 Million USD | -255.37% |
| 2023 Q1 | -109.26 Million USD | -57.73% |
| 2022 Q4 | -69.27 Million USD | 28.66% |
| 2022 Q3 | -97.1 Million USD | -42.71% |
| 2022 Q2 | -68.04 Million USD | 24.06% |
| 2022 Q1 | -89.59 Million USD | -29.01% |
| 2022 FY | -324.01 Million USD | -27.49% |
| 2021 Q3 | -96.7 Million USD | -108.2% |
| 2021 FY | -254.15 Million USD | -37.23% |
| 2021 Q4 | -69.44 Million USD | 28.18% |
| 2021 Q2 | -46.44 Million USD | -11.79% |
| 2021 Q1 | -41.55 Million USD | 38.06% |
| 2020 Q4 | -67.07 Million USD | -48.59% |
| 2020 FY | -185.19 Million USD | 13.36% |
| 2020 Q3 | -45.14 Million USD | -24.52% |
| 2020 Q2 | -36.25 Million USD | 1.27% |
| 2020 Q1 | -36.72 Million USD | 0.0% |
| 2019 FY | -213.75 Million USD | -13.23% |
| 2018 FY | -188.78 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | -230.08% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -2833.876% |
| Aspira Women's Health Inc. | -18.85 Million USD | -1604.626% |
| Biodesix, Inc. | -41.34 Million USD | -677.311% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -12290.403% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -3930.438% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -3930.438% |
| Bionano Genomics, Inc. | -215.24 Million USD | -49.298% |
| CareDx, Inc | -101.9 Million USD | -215.364% |
| Check-Cap Ltd. | -19.28 Million USD | -1566.179% |
| Castle Biosciences, Inc. | -67.97 Million USD | -372.742% |
| DarioHealth Corp. | -56.18 Million USD | -471.92% |
| Exact Sciences Corporation | -215.01 Million USD | -49.46% |
| Fulgent Genetics, Inc. | -72.69 Million USD | -342.061% |
| Guardant Health, Inc. | -564.72 Million USD | 43.095% |
| ICON Public Limited Company | 956.15 Million USD | 133.609% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 129.291% |
| Illumina, Inc. | -1.06 Billion USD | 69.939% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -3025.066% |
| iSpecimen Inc. | -11.16 Million USD | -2777.124% |
| Standard BioTools Inc. | -76.6 Million USD | -319.525% |
| MDxHealth SA | -27.32 Million USD | -1075.965% |
| Medpace Holdings, Inc. | 336.82 Million USD | 195.407% |
| Myriad Genetics, Inc. | -123.7 Million USD | -159.787% |
| Mainz Biomed B.V. | -26.64 Million USD | -1106.079% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -2954.501% |
| NeoGenomics, Inc. | -107.73 Million USD | -198.281% |
| Neogen Corporation | 58.66 Million USD | 647.8% |
| Inotiv, Inc. | -81.46 Million USD | -294.495% |
| Natera, Inc. | -446.24 Million USD | 27.987% |
| OpGen, Inc. | -15.68 Million USD | -1948.357% |
| OPKO Health, Inc. | -157.02 Million USD | -104.658% |
| Psychemedics Corporation | -2.92 Million USD | -10901.575% |
| Prenetics Global Limited | -52.51 Million USD | -511.949% |
| Prenetics Global Limited | -52.51 Million USD | -511.949% |
| Precipio, Inc. | -7.62 Million USD | -4117.27% |
| Personalis, Inc. | -109.93 Million USD | -192.312% |
| RadNet, Inc. | 98.69 Million USD | 425.599% |
| Sera Prognostics, Inc. | -39.82 Million USD | -707.001% |
| Sotera Health Company | 276.69 Million USD | 216.142% |
| Neuronetics, Inc. | -30.55 Million USD | -951.764% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -7294.294% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -7294.294% |
| Trinity Biotech plc | -27.04 Million USD | -1088.227% |
| T2 Biosystems, Inc. | -49.66 Million USD | -547.06% |
| Twist Bioscience Corporation | -220.83 Million USD | -45.521% |
| Exagen Inc. | -22.83 Million USD | -1307.173% |